IPO Boutique

ERYTECH Pharma S.A. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on ERYTECH Pharma S.A., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
ERYTECH Pharma S.A.ERYP -
NASDAQ
$23.00-$24.00 $23.26 $26.684.7 million ADSs11/10/2017
Jefferies, Cowen, Oddo BHF
Co-Manager(s):
JMP Securities
Health Care
Filing(s):

Final Prospectus 2017-11-13
Terms Added 2017-11-06
Filed 2017-10-06



ERYTECH Pharma S.A. Quote & Chart - Click for current quote - ERYP

About ERYTECH Pharma S.A. (adapted from ERYTECH Pharma S.A. prospectus):
They are a biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases. Their ordinary shares are listed on Euronext Paris under the symbol 'ERYP'.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "ERYP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2024 IPO Boutique. All Rights Reserved